Genetics of rheumatoid arthritis

Carl Turesson, Eric Lawrence Matteson

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Rheumatiod arthritis (RA) is a heterogeneous autoimmune disorder of unknown cause with variable clinical expression. Abort 70% of patients are women. Genetic factors play an important role and likely account for about 60% of disease susceptibility and expression. The association with the HLA-DRB1 gene is the best understood, although several non-HLA loci have been linked to RA, including the 18q21 region of the TNFRSR11A gene, which encodes the receptor activator of nuclear factor κB, important in bone resorption in RA. Genetic factors are also important in the treatment of RA because the activity of enzymes relevant in the metabolism of drugs such as methotrexate and azathioprine, including methylenetetrathydrofolate reductsse and thiopurine methyltransferase, are in part genetically determined.

Original languageEnglish (US)
Pages (from-to)94-101
Number of pages8
JournalMayo Clinic Proceedings
Volume81
Issue number1
StatePublished - Jan 2006

Fingerprint

Arthritis
Rheumatoid Arthritis
thiopurine methyltransferase
HLA-DRB1 Chains
Disease Susceptibility
Azathioprine
Bone Resorption
Cytoplasmic and Nuclear Receptors
Methotrexate
Genes
Enzymes
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Genetics of rheumatoid arthritis. / Turesson, Carl; Matteson, Eric Lawrence.

In: Mayo Clinic Proceedings, Vol. 81, No. 1, 01.2006, p. 94-101.

Research output: Contribution to journalArticle

Turesson, C & Matteson, EL 2006, 'Genetics of rheumatoid arthritis', Mayo Clinic Proceedings, vol. 81, no. 1, pp. 94-101.
Turesson, Carl ; Matteson, Eric Lawrence. / Genetics of rheumatoid arthritis. In: Mayo Clinic Proceedings. 2006 ; Vol. 81, No. 1. pp. 94-101.
@article{80a70694432a4f0486f9a47fe4147a78,
title = "Genetics of rheumatoid arthritis",
abstract = "Rheumatiod arthritis (RA) is a heterogeneous autoimmune disorder of unknown cause with variable clinical expression. Abort 70{\%} of patients are women. Genetic factors play an important role and likely account for about 60{\%} of disease susceptibility and expression. The association with the HLA-DRB1 gene is the best understood, although several non-HLA loci have been linked to RA, including the 18q21 region of the TNFRSR11A gene, which encodes the receptor activator of nuclear factor κB, important in bone resorption in RA. Genetic factors are also important in the treatment of RA because the activity of enzymes relevant in the metabolism of drugs such as methotrexate and azathioprine, including methylenetetrathydrofolate reductsse and thiopurine methyltransferase, are in part genetically determined.",
author = "Carl Turesson and Matteson, {Eric Lawrence}",
year = "2006",
month = "1",
language = "English (US)",
volume = "81",
pages = "94--101",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "1",

}

TY - JOUR

T1 - Genetics of rheumatoid arthritis

AU - Turesson, Carl

AU - Matteson, Eric Lawrence

PY - 2006/1

Y1 - 2006/1

N2 - Rheumatiod arthritis (RA) is a heterogeneous autoimmune disorder of unknown cause with variable clinical expression. Abort 70% of patients are women. Genetic factors play an important role and likely account for about 60% of disease susceptibility and expression. The association with the HLA-DRB1 gene is the best understood, although several non-HLA loci have been linked to RA, including the 18q21 region of the TNFRSR11A gene, which encodes the receptor activator of nuclear factor κB, important in bone resorption in RA. Genetic factors are also important in the treatment of RA because the activity of enzymes relevant in the metabolism of drugs such as methotrexate and azathioprine, including methylenetetrathydrofolate reductsse and thiopurine methyltransferase, are in part genetically determined.

AB - Rheumatiod arthritis (RA) is a heterogeneous autoimmune disorder of unknown cause with variable clinical expression. Abort 70% of patients are women. Genetic factors play an important role and likely account for about 60% of disease susceptibility and expression. The association with the HLA-DRB1 gene is the best understood, although several non-HLA loci have been linked to RA, including the 18q21 region of the TNFRSR11A gene, which encodes the receptor activator of nuclear factor κB, important in bone resorption in RA. Genetic factors are also important in the treatment of RA because the activity of enzymes relevant in the metabolism of drugs such as methotrexate and azathioprine, including methylenetetrathydrofolate reductsse and thiopurine methyltransferase, are in part genetically determined.

UR - http://www.scopus.com/inward/record.url?scp=30344465333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30344465333&partnerID=8YFLogxK

M3 - Article

VL - 81

SP - 94

EP - 101

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 1

ER -